annb0t
Top 20
ResMed Inc. RMD is well poised for growth in the coming quarters, backed by strong mask and device sales globally. Strength in the Software-as-a-Service ("SaaS") business continues to benefit the company. The ongoing uptake of both AirSense 11 and AirSense 10 platforms buoys optimism. However, weak margins and macroeconomic challenges raise apprehension.
In the past year, the Zacks Rank #2 (Buy) stock has lost 14.2% compared with a 32.3% fall of the industry and a 12.4% decline of the S&P 500.
...
>>> Read more: Reasons Why You Should Invest in ResMed (RMD) Stock Now
In the past year, the Zacks Rank #2 (Buy) stock has lost 14.2% compared with a 32.3% fall of the industry and a 12.4% decline of the S&P 500.
...
>>> Read more: Reasons Why You Should Invest in ResMed (RMD) Stock Now
